Mylan NV
(NASDAQ : MYL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.20%166.012.9%$476.36m
ZTSZoetis, Inc. Class A
-0.61%120.951.9%$227.16m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-3.06%7.932.0%$173.28m
MYLMylan N.V.
-2.47%21.693.2%$107.10m
TXMDTherapeuticsMD, Inc.
2.09%3.4224.9%$8.00m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-1.12%38.782.0%$6.36m
ABEOAbeona Therapeutics, Inc.
-5.41%2.977.6%$5.55m
TAROTaro Pharmaceutical Industries Ltd.
2.46%81.806.4%$4.93m
JAGXJaguar Animal Health, Inc.
0.00%1.339.8%$2.26m
KINKindred Biosciences, Inc.
13.74%8.030.3%$1.11m
LFVNLifeVantage Corporation
-1.50%13.103.3%$0.96m
CPHIChina Pharma Holdings, Inc.
0.71%0.270.1%$0.04m

Company Profile

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.